Viasat, Inc (VSAT) stock analysis: A simple moving average approach

While Viasat, Inc has overperformed by 1.14%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VSAT fell by -0.75%, with highs and lows ranging from $26.70 to $6.69, whereas the simple moving average jumped by 31.98% in the last 200 days.

On March 24, 2025, Deutsche Bank Upgraded Viasat, Inc (NASDAQ: VSAT) to Buy. A report published by Cantor Fitzgerald on January 24, 2025, Initiated its previous ‘Neutral’ rating for VSAT. Needham also reiterated VSAT shares as ‘Buy’, quoting a target price of $19 on the company’s shares in a report dated October 15, 2024. JP Morgan September 17, 2024d the rating to Neutral on September 17, 2024, and set its price target from $29 to $15. JP Morgan October 17, 2023d its ‘Neutral’ rating to ‘Overweight’ for VSAT, as published in its report on October 17, 2023. Deutsche Bank’s report from October 17, 2023 suggests a price prediction of $22 for VSAT shares, giving the stock a ‘Hold’ rating. JP Morgan also rated the stock as ‘Neutral’.

Analysis of Viasat, Inc (VSAT)

Further, the quarter-over-quarter decrease in sales is -0.25%, showing a negative trend in the upcoming months.

Viasat, Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -12.00% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.55, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and VSAT has an average volume of 3.27M. On a monthly basis, the volatility of the stock is set at 5.17%, whereas on a weekly basis, it is put at 4.33%, with a gain of 21.22% over the past seven days. Furthermore, long-term investors anticipate a median target price of $18.29, showing growth from the present price of $13.31, which can serve as yet another indication of whether VSAT is worth investing in or should be passed over.

How Do You Analyze Viasat, Inc Shares?

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 13.17%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 95.03% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

VSAT shares are owned by institutional investors to the tune of 95.03% at present.

Hot this week

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

Topics

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

A stock that deserves closer examination: Perpetua Resources Corp (PPTA)

While Perpetua Resources Corp has overperformed by 2.68%, investors...

Perspective Therapeutics Inc (CATX) deserves deeper analysis

While Perspective Therapeutics Inc has underperformed by -2.27%, investors...

Was Foremost Clean Energy Ltd (FMST)’s session last reading good?

While Foremost Clean Energy Ltd has overperformed by 2.80%,...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.